The story of Rosie, an eight-year-old Staffy cross Shar Pei from Sydney whose owner used AI and genomic sequencing to design a personalised mRNA cancer vaccine, captured global attention in early 2026. It is a genuinely remarkable case. It is also widely misread, and...
A research team at the Hong Kong University of Science and Technology has done something that was not supposed to be possible: they have flipped the fundamental logic of CRISPR gene editing. Published in Nature Biotechnology this month, the work by Professor Hsing...
Federal Budget 2026–27 — What It Means for Genomics and Precision Medicine The 2026–27 Federal Budget provides several positive signals for genomics and precision medicine in Australia, particularly across precision oncology, clinical trials, medicines access, digital...
InGeNA releases Position Statement on Genomics for Prevention and Population Screening InGeNA has released its new Position Statement on Genomics for Prevention and Population Screening, outlining the organisation’s support for the responsible, coordinated, and...
2025’s Gene Therapy Breakthroughs Show the Future of Genomics in Action A new era of precision medicine is taking shape with remarkable speed, and few recent developments exemplify this better than the success of CRISPR-based and gene therapy interventions for rare...
InGeNA CEO Appointed to Genomics Australia Advisory Council We’re proud to share that InGeNA CEO Dr Erin Evans has been appointed as one of seven individual members of the newly formed Genomics Australia Advisory Council, chaired by the Genomics Commissioner Tiffany...
